Studies show B12 deficiency affects DNA formation and metabolic pathways through epigenetic alterations, including changes in histone acetylation, histone methylation, and interactions with histone deacetylases
The Endocrine Society's 2023 clinical practice guidelines on obesity pharmacotherapy note that "the absence of safety data in humans should not be conflated with a safety guarantee, particularly when preclinical mechanisms suggest CNS activity" [11]
Stability in stomach acid is also a unique property of BPC-157, which makes it possible to develop oral forms of the drug, although injectable ones are often considered more effective in specific applications
At 2.5 mg, a short outpatient cohort measured about -4.7% body weight over roughly four weeks. How is draw volume calculated for a tirzepatide microdose
Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus